For further details see:
Amgen and Kyowa Kirin in pact for experimental atopic dermatitis therapyhome / stock / kykof / kykof news
For further details see:
Amgen and Kyowa Kirin in pact for experimental atopic dermatitis therapyMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Kyowa Hakko Kogyo Company Name:
KYKOF Stock Symbol:
Market:
TOKYO , Jan. 6, 2020 /PRNewswire/ -- Kyowa Kirin Co., Ltd. (TSE: 4151) President and CEO: Masashi Miyamoto , "Kyowa Kirin") today announces that its marketing authorisation application (MAA) for istradefylline (KW-6002) as an adjunctive treatment to levodopa-based regimens in adult patie...